Pancreatic acinar cell carcinoma is a rare form (0.2–4.3%) of pancreatic neoplasm with
unique clinical and molecular characteristics, which largely differ from pancreatic ductal …

Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with
high mortality. Most patients present with an advanced stage of the disease, highlighting the …

Infiltrating ductal adenocarcinoma of the pancreas, referred to here as “pancreatic cancer,” is
one of the deadliest of all of the solid malignancies. The five-year survival rate in the United …

A 73-year-old Japanese man with a history of distal biliary cancer treated by
pancreatoduodenectomy developed pancreatic acinar cell carcinoma (PACC) treated by …

Importance Half of all carriers of inherited cancer-predisposing variants
inBRCA1andBRCA2are male, but the implications for their health are underrecognized …

Screening programs for early detection and treatment of pancreatic cancer (PC) and its
precursor lesions are increasingly implemented worldwide to reduce disease-specific …

Background Pancreatic acinar cell carcinoma (pACC) is a rare neoplasm of the exocrine
pancreas. There is a dearth of information about tumor characteristics and patient outcomes …

Simple Summary We present a case series of 16 patients with pancreatic acinar cell
carcinoma treated at our institution for whom available molecular information was evaluated …

Pancreatic cancer is one of the deadliest malignancies in humans and it is expected to play
a bigger part in cancer burden in the years to come. Pancreatic ductal adenocarcinoma …

Exceptional Response of BRAFV600E-Mutated Acinar Cell CUP to BRAF/MEK Inhibition | JCO
Precision Oncology Skip to main content ASCO Publications Publications Journal of Clinical …